𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enhancement of copper resistance and CupI amplification in carcinogen-treated yeast cells

✍ Scribed by Aladjem, Mirit I. ;Koltin, Yigal ;Lavi, Sara


Publisher
Springer
Year
1988
Tongue
English
Weight
780 KB
Volume
211
Category
Article
ISSN
0026-8925

No coin nor oath required. For personal study only.

✦ Synopsis


Carcinogen-induced amplification at the CupI locus, coding for a metallothionein protein, was studied in the yeast Saccharomyces cerevisiae. Exposure of cells from three different haploid strains, 4939, DBY746 and 320, to chemical carcinogens such as N-methyl-N'-nitro-N-nitroso-guanidine (MNNG), ethylmethanesulfonate (EMS) and 4-nitroquinoline-N-oxide (4NQO) enhanced the frequency of copper-resistant colonies up to several hundred fold. Copper-resistant clones obtained from strains DBY746 and 320, which contain more than one copy of the CupI locus, displayed a four- to eightfold amplification of the CupI sequences. In these clones the amplified CupI sequences were organized in a tandem array. Carcinogen treatment of strain 4939 in which only one copy of the CupI gene is present produced resistant colonies without CupI amplification. The possible use of the yeast system to study gene duplication and amplification is discussed.


📜 SIMILAR VOLUMES


Amplification of the metallothionein-1 a
✍ Mark J. Czaja; Francis R. Weiner; Jonathan H. Freedman 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

The molecular basis for increased metallothionein concentrations in copperresistant hepatoma cells was examined. The copper-resistant cell line HAC, , , , which is maintained in 600 k m copper, had increased steady-state mRNA levels for both the metallothionein-1 (MT-1) and the metallothionein-2 (MT

Enhancement by TPA of phenotypes associa
✍ Jill M. Siegfried; David G. Kaufman 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 French ⚖ 911 KB

## Abstract The tumor promoter 12‐O‐tetradecanoylphorbol 13‐acetate (TPA) was found to increase the incidence of phenotypic alterations induced by the direct‐acting carcinogen N‐methyl‐N‐nitro‐N‐nitrosoguanidine (MNNG) in human endometrial stromal cells. Following carcinogen treatment, changes in s